Prospective study of phobic anxiety and risk of Parkinson's disease

Movement Disorders

Volumn 18, Issue 6, 2003, Pages 646-651

  Weisskopf, Marc G ^a   Chen, Honglei ^a   Schwarzschild, Michael A ^b   Kawachi, Ichiro ^a,c   Ascherio, Alberto ^a,c  

^a HARVARD SCHOOL OF PUBLIC HEALTH   (United States)

^b MASSACHUSETTS GENERAL HOSPITAL   (United States)

^c BRIGHAM AND WOMEN S HOSPITAL   (United States)

Author keywords

Anxiety; Epidemiology; Parkinsons disease; Prospective studies; Risk factors

Indexed keywords

ANXIOLYTIC AGENT; CAFFEINE;

ADULT; AGE; AGED; ARTICLE; CANCER; COHORT ANALYSIS; CONTROLLED STUDY; DISEASE ASSOCIATION; FOLLOW UP; HEALTH PRACTITIONER; HUMAN; INCIDENCE; MALE; PARKINSON DISEASE; PHOBIA; PRIORITY JOURNAL; PROSPECTIVE STUDY; PSYCHOLOGIC ASSESSMENT; PSYCHOLOGIC TEST; RISK ASSESSMENT; RISK FACTOR; SCORING SYSTEM; SMOKING; STROKE; UNITED STATES;

ADULT; AGED; FEMALE; FOLLOW-UP STUDIES; HEALTH PERSONNEL; HUMANS; LIFE STYLE; MALE; MIDDLE AGED; PARKINSON DISEASE; PHOBIC DISORDERS; PROSPECTIVE STUDIES; QUESTIONNAIRES; RISK ASSESSMENT; RISK FACTORS; UNITED STATES;

EID: 0038084268     PISSN: 08853185     EISSN: None     Source Type: Journal    
DOI: 10.1002/mds.10425     Document Type: Article

References (39)

1. Richards A, French CC, Randall F. Anxiety and the use of strategies in the performance of a sentence-picture verification task. J Abnorm Psychol 1996;105:132-136.
2. Walsh K, Bennett G. Parkinson's disease and anxiety. Postgrad Med J 2001;77:89-93.
3. Stein MB, Heuser IJ, Juncos JL, Uhde TW. Anxiety disorders in patients with Parkinson's disease. Am J Psychiatry 1990;147:217-220.
4. Vazquez A, Jimenez-Jimenez FJ, Garcia-Ruiz P, Garcia-Urra D. "Panic attacks" in Parkinson's disease. A long-term complication of levodopa therapy. Acta Neurol Scand 1993;87:14-18.
5. Henderson R, Kurlan R, Kersun JM, Como P. Preliminary examination of the comorbidity of anxiety and depression in Parkinson's disease. J Neuropsychiatry Clin Neurosci 1992;4:257-264.
6. Schiffer RB, Kurlan R, Rubin A, Boer S. Evidence for atypical depression in Parkinson's disease. Am J Psychiatry 1988;145: 1020-1022.
7. Lauterbach EC, Duvoisin RC. Anxiety disorders in familial parkinsonism. Am J Psychiatry 1991;148:274.
8. Rajput AH, Offord KP, Beard CM, Kurland LT. A case-control study of smoking habits, dementia, and other illnesses in idiopathic Parkinson's disease. Neurology 1987;37:226-232.
9. Shiba M, Bower JH, Maraganore DM, et al. Anxiety disorders and depressive disorders preceding Parkinson's disease: a case-control study. Mov Disord 2000;15:669-677.
10. Menza MA, Robertson-Hoffman DE, Bonapace AS. Parkinson's disease and anxiety: comorbidity with depression. Biol Psychiatry 1993;34:465-470.
11. Menza MA, Mark MH. Parkinson's disease and depression: the relationship to disability and personality. J Neuropsychiatry Clin Neurosci 1994;6:165-169.
12. Crown S, Crisp AH. A short diagnostic self-rating scale for psychoneurotic patients: the Middlesex Hospital Questionnaire. Br J Psychiatry 1956; 112:917-923.
13. Rimm EB, Giovannucci EL, Willett WC, Colditz GA, Ascherio A, Rosner B, Stampfer MJ. Prospective study of alcohol consumption and risk of coronary disease in men. Lancet 1991;338:464-468.
14. Ascherio A, Zhang SM, Hernan MA, Kawachi I, Colditz GA, Speizer FE, Willett WC. Prospective study of caffeine consumption and risk of Parkinson's disease in men and women. Ann Neurol 2001;50:56-63.
15. Hughes AJ, Daniel SE, Lees AJ. Improved accuracy of clinical diagnosis of Lewy body Parkinson's disease. Neurology 2001;57: 1497-1499.
16. Kawachi I, Colditz GA, Ascherio A, Rimm EB, Giovannucci E, Stampfer MJ, Willett WC. Prospective study of phobic anxiety and risk of coronary heart disease in men. Circulation 1994;89:1992-1997.
17. Salmons P, Sims A. Smoking profiles of patients admitted for neurosis. Br J Psychiatry 1981;139:43-46.
18. Mathew SJ, Coplan JD, Gorman JM. Neurobiological mechanisms of social anxiety disorder. Am J Psychiatry 2001;158:1558-1567.
19. Nutt DJ, Bell CJ, Malizia AL. Brain mechanisms of social anxiety disorder. J Clin Psychiatry 1998;59:4-11.
20. Nutt D, Lawson C. Panic attacks. A neurochemical overview of models and mechanisms. Br J Psychiatry 1992;160:165-178.
21. Heninger GR, Charney DS. Monoamine receptor systems and anxiety disorders. Psychiatr Clin North Am 1988;11:309-326.
22. Mayeux R, Stern Y, Williams JB, Cote L, Frantz A, Dyrenfurth I. Clinical and biochemical features of depression in Parkinson's disease. Am J Psychiatry 1986;143:756-759.
23. German DC, Manaye KF, White CL 3rd, et al. Disease-specific patterns of locus coeruleus cell loss. Ann Neurol 1992;32:667-676.
24. 125I-α-conotoxin MII binding sites to nigrostriatal damage in monkey. J Neurosci 2001;21:5494-5500.
25. Quik M, Polonskaya Y, Gillespie A, K Lloyd G, Langston JW. Differential alterations in nicotinic receptor α6 and β3 subunit messenger RNAs in monkey substantia nigra after nigrostriatal degeneration. Neuroscience 2000;100:63-72.
26. Perry EK, Morris CM, Court JA, et al. Alteration in nicotine binding sites in Parkinson's disease, Lewy body dementia and Alzheimer's disease: possible index of early neuropathology. Neuroscience 1995;64:385-395.
27. Ross SA, Wong JY, Clifford JJ, et al. Phenotypic characterization of an α4 neuronal nicotinic acetylcholine receptor subunit knockout mouse. J Neurosci 2000;20:6431-6441.
28. Labarca C, Schwarz J, Deshpande P, et al. Point mutant mice with hypersensitive α4 nicotinic receptors show dopaminergic deficits and increased anxiety. Proc Natl Acad Sci U S A 2001;98:2786-2791.
29. Menza M. The personality associated with Parkinson's disease. Curr Psychiatry Rep 2000;2:421-426.
30. Levine J, Cole DP, Chengappa KN, Gershon S. Anxiety disorders and major depression, together or apart. Depress Anxiety 2001;14: 94-104.
31. Sheehan DV. Current concepts in psychiatry. Panic attacks and phobias. N Engl J Med 1982;307:156-158.
32. Brandon S. Panic disorder: A new entity? Br J Hosp Med 1989; 41:319.
33. Crisp AH, Queenan M, D'Souza MF. Myocardial infarction and the emotional climate. Lancet 1984;1:616-619.
34. Haines AP, Imeson JD, Meade TW. Phobic anxiety and ischaemic heart disease. Br Med J (Clin Res Ed) 1987;295:297-299.
35. Hartman D, Crisp AH, Sedgwick P, Borrow S. Is there a dissociative process in sleepwalking and night terrors? Postgrad Med J 2001;77:244-249.
36. Kelly WF, Kelly MJ, Faragher B. A prospective study of psychiatric and psychological aspects of Cushing's syndrome. Clin Endocrinol 1996;45:715-720.
37. Olley BO, Osinowo HO, Brieger WR. Psycho-educational therapy among Nigerian adult patients with epilepsy: a controlled outcome study. Patient Educ Couns 2001;42:25-33.
38. Alderman KJ, Mackay CJ, Lucas EG, Spry WB, Bell B. Factor analysis and reliability studies of the Crown-Crisp experiential index (CCEI). Br J Med Psychol 1983;56:329-345.
39. Kaplan HI, Sadock BJ. Comprehensive textbook of psychiatry. Fourth ed. Baltimore, MD: Williams and Wilkins, 1985. p 894-904.